How long do people take Wegovy, and what does the evidence say?

What the clinical trials actually measured

The pivotal STEP 1 trial, published in the New England Journal of Medicine, ran for 68 weeks and found an average body-weight reduction of around 15% at the 2.4mg maintenance dose alongside lifestyle changes. That 68-week window was not chosen arbitrarily; it reflects the time needed to reach maximum dose, sustain it, and observe a meaningful plateau. Participants who stayed on treatment kept losing weight across most of the trial period before levelling off in the final weeks.

A separate extension study then followed what happened when people stopped. Weight regained substantially — roughly two thirds of lost weight returned within a year of stopping. That finding reshaped how clinicians think about duration. Wegovy is not a short course in the way an antibiotic is; the biology that drives weight gain does not simply switch off when treatment ends.

This is a question our prescribers hear most weeks: "Can I just take it for a few months and then stop?" The short answer is that some people do stop after reaching their target, but the evidence suggests most will need ongoing support, whether that is continued treatment, intensive lifestyle input, or both. That conversation belongs with a prescriber who knows your full picture, not a general estimate from a webpage.

How long NICE says semaglutide should be used on the NHS

NICE's technology appraisal TA875 recommends semaglutide for weight management only within a specialist multidisciplinary service and for a maximum of two years. That two-year ceiling reflects both the trial evidence base at the time of appraisal and the NHS's commissioning framework, which treats these medicines as part of a structured programme rather than indefinite pharmacotherapy.

NICE also specifies that if someone has not achieved at least 5% weight loss after six months on their maintenance dose, continuing is unlikely to be clinically justified. That review point matters: it means the decision to keep going is actively reassessed, not assumed.

It is worth noting that the two-year cap applies specifically to the NHS pathway described in TA875. Private prescribing follows the licensed SmPC and individual clinical judgement. For context on how long Wegovy can be taken under different clinical circumstances, the picture is more nuanced than a single number suggests.

What happens to weight after stopping, and what that means for planning

The weight-regain data are consistent enough that prescribers now treat long-term management as part of the treatment plan from the outset, not an afterthought. Semaglutide works by suppressing appetite signals and slowing gastric emptying; when the medicine is no longer present, those signals return to their previous levels. For most people, the underlying physiology has not changed.

That does not mean everyone regains all lost weight. Sustained lifestyle changes (particularly building strength activity and shifting dietary habits during treatment) can slow regain. But the research is clear that lifestyle alone, without continued pharmacological support, rarely maintains the full reduction achieved on treatment.

People weighing up how quickly Wegovy starts working are often thinking about a short window; the evidence suggests the more useful question is what the plan looks like at month six, month twelve, and beyond. If you are considering Wegovy privately and want to understand how long people are typically on Wegovy before deciding whether to continue or stop, the full Wegovy overview is a useful starting point.

How duration fits into private treatment through a regulated pharmacy

At a GPhC-registered online pharmacy like nume, there is no subscription that auto-renews regardless of your progress. Every repeat order goes through a fresh clinical review by a GPhC-registered Independent Prescriber. That means your treatment duration is not set by a billing cycle; it is shaped by whether continuing is still clinically appropriate for you specifically.

For people tracking their rate of weight loss, the six-month review point that NICE and most prescribers use is a natural checkpoint to assess whether to continue, adjust, or take a planned break, and it is also a good moment to consider how long people tend to stay on Wegovy before making a decision about ongoing treatment. Pricing across the treatment course is something to factor in early; the treatment page shows what a private prescription through nume includes. Speak to our prescribers to understand what a realistic treatment timeline might look like for you.